- Forums
- ASX - By Stock
- ALL
- ALL - 'ALL in ' Why ALL is a defensive against
ALL - 'ALL in ' Why ALL is a defensive against, page-48
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$53.66 |
Change
0.740(1.40%) |
Mkt cap ! $33.79B |
Open | High | Low | Value | Volume |
$53.31 | $53.75 | $52.97 | $51.28M | 957.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2605 | $53.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$53.69 | 4762 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 492 | 58.350 |
2 | 558 | 58.220 |
1 | 624 | 58.110 |
6 | 45847 | 58.030 |
2 | 17511 | 57.650 |
Price($) | Vol. | No. |
---|---|---|
48.370 | 3601 | 7 |
49.690 | 205 | 1 |
50.180 | 11847 | 9 |
50.570 | 1070 | 2 |
51.020 | 7182 | 8 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ALL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online